Solventum director granted 3,300 RSUs

Solventum Corp director Susan D. DeVore received a grant of 3,300 Restricted Stock Units (RSUs) that convert into the same number of common shares upon settlement.

Rhea-AI Filing Summary

Solventum Corp director Susan D. DeVore received a grant of 3,300 Restricted Stock Units (RSUs) that convert into the same number of common shares upon settlement. The award was given at no cash cost to her and represents equity-based compensation rather than an open-market purchase.

The RSUs are scheduled to fully vest on May 15, 2027, provided she continues to serve through that date. Following this grant, her reported holdings in RSUs tied to common stock total 3,300 units, aligning her compensation more closely with future company performance.

Insider Trade Summary

Grant/Award: 3,300 shares

Grant/Award 1 txn

Insider DeVore Susan D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	3,300	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 3,300 contracts (Direct)

Footnotes (2)

1. F1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. F2. The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Key Figures

RSUs granted: 3,300 units RSUs underlying shares: 3,300 shares Grant price: $0.00 per unit +2 more

5 metrics

RSUs granted 3,300 units Restricted Stock Units granted to director on May 15, 2026

RSUs underlying shares 3,300 shares Each RSU represents 1 share of common stock

Grant price $0.00 per unit Equity award, no cash paid by reporting person

Post-grant RSU holdings 3,300 units Total RSUs held following this transaction

Vesting date May 15, 2027 RSUs fully vest subject to continued service

Key Terms

Restricted Stock Units, RSU, vesting, Common Stock

4 terms

Restricted Stock Units financial

"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vesting financial

"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Solventum (SOLV) director Susan DeVore report on this Form 4?

Director Susan D. DeVore reported receiving 3,300 Restricted Stock Units as equity compensation. Each RSU represents a contingent right to one Solventum common share, subject to future vesting conditions and continued service with the company.

How many Solventum (SOLV) shares are linked to Susan DeVore’s new RSU grant?

The grant covers 3,300 Restricted Stock Units, each tied to one share of Solventum common stock. If all vesting conditions are satisfied, the RSUs can settle into 3,300 common shares for the reporting person.

When do Susan DeVore’s Solventum (SOLV) RSUs vest?

The RSUs are scheduled to fully vest on May 15, 2027, subject to continued service through the vesting date. If she remains in service until then, the units become eligible for settlement into common shares.

Did Susan DeVore buy or sell Solventum (SOLV) shares in this filing?

This filing shows an acquisition through a grant of 3,300 RSUs, not an open-market stock purchase or sale. It reflects compensation awarded in stock units rather than trading activity in the public market.

What is a Restricted Stock Unit (RSU) in the context of Solventum (SOLV)?

A Restricted Stock Unit is a promise to deliver a share of common stock in the future if conditions are met. Here, each RSU represents one Solventum share, contingent on the director meeting the vesting requirement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 05:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeVore Susan D.

(Last) (First) (Middle)

1750 YANKEE DOODLE ROAD

(Street)

EAGAN MINNESOTA 55121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/15/2026		A		3,300		(2)	(2)	Common Stock	3,300	$0	3,300	D

Explanation of Responses:

1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

2. The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Remarks:

	/s/Megan Bombick, attorney-in-fact for Susan D. DeVore	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)